Viewing StudyNCT00479739



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00479739
Status: COMPLETED
Last Update Posted: 2016-09-15
First Post: 2007-05-25

Brief Title: CONCEPT A 1-Year Comparison Of A Stable Dose Of SERETIDE Inhaler With An Adjustable Maintenance Dose Of SYMBICORT Inhaler SERETIDE Inhaler is a Trademark of GSK Group of Companies SYMBICORT Inhaler is a Trademark of Astra Zeneca
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Asthma
Keywords:
Name View
asthma control View
formoterolbudesonide View
exacerbations View
Salmeterolfluticasone propionate View
adjustable maintenance dosing View